Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
A Collaborative Community Effort using belantamab mafodotin in Relapsed/Refractory Myeloma
Clinical Trial Grant
Duke Scholars
Principal Investigator
Cristiana A. Costa
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
GlaxoSmithKline
Start Date
March 3, 2023
End Date
February 28, 2030
Awarded By
GlaxoSmithKline
Start Date
March 3, 2023
End Date
February 28, 2030
